Brief: Aptose Biosciences Reports Qtrly Net Loss Per Share Of $0.13
06/08/2019 21:37
Aug 6 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE
30,
2019
* APTOSE BIOSCIENCES INC QTRLY NET LOSS PER SHARE $0.13
* APTOSE - CASH ON HAND, COMMITTED CAPITAL PROVIDE CO
SUFFICIENT
RESOURCES TO FUND ALL PLANNED OPERATIONS INCLUDING RESEARCH AND
DEVELOPMENT INTO 2H 2020
Source text for Eikon: ID:nGNX8DfsH3
Further company coverage: APS.TO
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting